These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 33689541)

  • 1. Decreased emotional creativity and its relationship with cognitive functions in Parkinson's disease: A preliminary study.
    Nikolai T; Sulc Z; Balcar K; Kuška M; Plzakova V; Slavickova T; Trnka R
    Appl Neuropsychol Adult; 2022; 29(6):1484-1491. PubMed ID: 33689541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emotional and cognitive social processes are impaired in Parkinson's disease and are related to behavioral disorders.
    Narme P; Mouras H; Roussel M; Duru C; Krystkowiak P; Godefroy O
    Neuropsychology; 2013 Mar; 27(2):182-92. PubMed ID: 23527646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests.
    Hoogland J; van Wanrooij LL; Boel JA; Goldman JG; Stebbins GT; Dalrymple-Alford JC; Marras C; Adler CH; Junque C; Pedersen KF; Mollenhauer B; Zabetian CP; Eslinger PJ; Lewis SJG; Wu RM; Klein M; Rodriguez-Oroz MC; Cammisuli DM; Barone P; Biundo R; de Bie RMA; Schmand BA; Tröster AI; Burn DJ; Litvan I; Filoteo JV; Geurtsen GJ; Weintraub D;
    Mov Disord; 2018 Nov; 33(11):1750-1759. PubMed ID: 30216541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between olfactory loss and cognitive deficits in Parkinson's disease.
    Camargo CHF; Jobbins VA; Serpa RA; Berbetz FA; Sabatini JS; Teive HAG
    Clin Neurol Neurosurg; 2018 Oct; 173():120-123. PubMed ID: 30121454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of cognitive impairment in patients with Parkinson's disease: prevalence and risk factors.
    Wang Q; Zhang Z; Li L; Wen H; Xu Q
    Clin Interv Aging; 2014; 9():275-81. PubMed ID: 24550669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computerized testing in Parkinson's disease: Performance deficits in relation to standard clinical measures.
    Flannery SL; Jowett T; Garvey A; Cutfield NJ; Machado L
    J Clin Exp Neuropsychol; 2018 Dec; 40(10):1062-1073. PubMed ID: 29978753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients.
    Pellecchia MT; Santangelo G; Picillo M; Pivonello R; Longo K; Pivonello C; Vitale C; Amboni M; De Rosa A; Moccia M; Erro R; De Michele G; Santoro L; Colao A; Barone P
    J Neurol; 2013 Feb; 260(2):438-44. PubMed ID: 22911513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson's disease.
    Hong JY; Yun HJ; Sunwoo MK; Ham JH; Lee JM; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2014 Sep; 20(9):999-1003. PubMed ID: 25001316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Parkinson's Disease-Cognitive Rating Scale (PD-CRS): normative values from 268 healthy Italian individuals.
    Santangelo G; Lagravinese G; Battini V; Chiorri C; Siciliano M; Abbruzzese G; Vitale C; Barone P
    Neurol Sci; 2017 May; 38(5):845-853. PubMed ID: 28224328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Italian version of the alternative form of Parkinson's Disease-Cognitive Rating Scale (PD-CRS/AF): normative values from 260 Italian healthy subjects.
    D'Iorio A; Maggi G; Baiano C; Santangelo G
    Neurol Sci; 2022 Jun; 43(6):3613-3620. PubMed ID: 35083571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Parkinson's Disease-Cognitive Rating Scale: Greek Normative Data, Clinical Utility and Cultural Considerations.
    Aretouli E; Chondrogiorgi M; Dede O; Koutsonida M; Lafi C; Konstantinopoulou E; Kulisevsky J; Kosmidis MH; Konitsiotis S
    J Geriatr Psychiatry Neurol; 2022 Sep; 35(5):680-688. PubMed ID: 34663111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance.
    Burdick DJ; Cholerton B; Watson GS; Siderowf A; Trojanowski JQ; Weintraub D; Ritz B; Rhodes SL; Rausch R; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Srivatsal S; Edwards KL; Montine TJ; Zabetian CP; Leverenz JB
    Mov Disord; 2014 Sep; 29(10):1258-64. PubMed ID: 25073717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Cognitive-Driven Performance-Based Activities of Daily Living Dysfunction in Parkinson's Disease.
    Sulzer P; Bäumer A; Hoang HG; Becker S; Lönneker HD; Graessel E; Liepelt-Scarfone I
    J Int Neuropsychol Soc; 2020 Apr; 26(4):430-440. PubMed ID: 31822319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson's disease.
    Montanaro E; Romagnolo A; Fabbri M; Artusi CA; Imbalzano G; Rizzone MG; Lopiano L; Zibetti M
    J Neurol; 2022 Mar; 269(3):1538-1545. PubMed ID: 34328543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease.
    Biundo R; Weis L; Pilleri M; Facchini S; Formento-Dojot P; Vallelunga A; Antonini A
    J Neural Transm (Vienna); 2013 Apr; 120(4):627-33. PubMed ID: 23483334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Empathy Scores in Patients with Parkinson's Disease: A Non-Motor Symptom Associated with Advanced Disease Stages.
    Schmidt N; Paschen L; Deuschl G; Witt K
    J Parkinsons Dis; 2017; 7(4):713-718. PubMed ID: 28759973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mini-mental Parkinson's (MMP) as a cognitive screening tool in people with Parkinson's disease.
    Caslake R; Summers F; McConachie D; Ferris C; Gordon J; Harris C; Caie L; Counsell C
    Curr Aging Sci; 2013 Dec; 6(3):273-9. PubMed ID: 23773030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.